As a laboratory study may not always recapitulate the clinical malignancy, we performed immunohistochemistry staining (IHC) to examine CDH11, ILF3 and HOXC8 protein levels in breast cancer specimens and normal breast tissues. This evidence concerns the gene CDH11 and breast cancer.